Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Validity of a web-based dietary questionnaire designed especially to measure the intake of phyto-oestrogens.

Nybacka S, Bertéus Forslund H, Hedelin M.

J Nutr Sci. 2016 Sep 9;5:e36. eCollection 2016.

2.

Development and Validation of a Photographic Method to Use for Dietary Assessment in School Settings.

Olafsdottir AS, Hörnell A, Hedelin M, Waling M, Gunnarsdottir I, Olsson C.

PLoS One. 2016 Oct 6;11(10):e0163970. doi: 10.1371/journal.pone.0163970. eCollection 2016.

3.

Prospective Study of Dietary Phytoestrogen Intake and the Risk of Colorectal Cancer.

Hedelin M, Löf M, Sandin S, Adami HO, Weiderpass E.

Nutr Cancer. 2016;68(3):388-95. doi: 10.1080/01635581.2016.1152380. Epub 2016 Mar 24.

PMID:
27010988
4.

Intrusive thoughts and quality of life among men with prostate cancer before and three months after surgery.

Thorsteinsdottir T, Hedelin M, Stranne J, Valdimarsdóttir H, Wilderäng U, Haglind E, Steineck G; LAPPROSteering Committee.

Health Qual Life Outcomes. 2013 Sep 11;11:154. doi: 10.1186/1477-7525-11-154.

5.

Mean absorbed dose to the anal-sphincter region and fecal leakage among irradiated prostate cancer survivors.

Alsadius D, Hedelin M, Lundstedt D, Pettersson N, Wilderäng U, Steineck G.

Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):e181-5. doi: 10.1016/j.ijrobp.2012.03.065. Epub 2012 Jun 5.

PMID:
22677373
6.

Tobacco smoking and long-lasting symptoms from the bowel and the anal-sphincter region after radiotherapy for prostate cancer.

Alsadius D, Hedelin M, Johansson KA, Pettersson N, Wilderäng U, Lundstedt D, Steineck G.

Radiother Oncol. 2011 Dec;101(3):495-501. doi: 10.1016/j.radonc.2011.06.010. Epub 2011 Jul 5.

PMID:
21737169
7.

Dietary phytoestrogens and the risk of ovarian cancer in the women's lifestyle and health cohort study.

Hedelin M, Löf M, Andersson TM, Adlercreutz H, Weiderpass E.

Cancer Epidemiol Biomarkers Prev. 2011 Feb;20(2):308-17. doi: 10.1158/1055-9965.EPI-10-0752. Epub 2010 Nov 23.

8.

Dietary supplement use patterns in men with prostate cancer: the Cancer Prostate Sweden study.

Westerlund A, Steineck G, Bälter K, Stattin P, Grönberg H, Hedelin M.

Ann Oncol. 2011 Apr;22(4):967-72. doi: 10.1093/annonc/mdq456. Epub 2010 Oct 6.

PMID:
20926547
9.

Dietary intake of fish, omega-3, omega-6 polyunsaturated fatty acids and vitamin D and the prevalence of psychotic-like symptoms in a cohort of 33,000 women from the general population.

Hedelin M, Löf M, Olsson M, Lewander T, Nilsson B, Hultman CM, Weiderpass E.

BMC Psychiatry. 2010 May 26;10:38. doi: 10.1186/1471-244X-10-38.

11.

Lactase persistence, dietary intake of milk, and the risk for prostate cancer in Sweden and Finland.

Torniainen S, Hedelin M, Autio V, Rasinperä H, Bälter KA, Klint A, Bellocco R, Wiklund F, Stattin P, Ikonen T, Tammela TL, Schleutker J, Grönberg H, Järvelä I.

Cancer Epidemiol Biomarkers Prev. 2007 May;16(5):956-61.

12.

Association of frequent consumption of fatty fish with prostate cancer risk is modified by COX-2 polymorphism.

Hedelin M, Chang ET, Wiklund F, Bellocco R, Klint A, Adolfsson J, Shahedi K, Xu J, Adami HO, Grönberg H, Bälter KA.

Int J Cancer. 2007 Jan 15;120(2):398-405.

13.

Dietary intake of phytoestrogens, estrogen receptor-beta polymorphisms and the risk of prostate cancer.

Hedelin M, Bälter KA, Chang ET, Bellocco R, Klint A, Johansson JE, Wiklund F, Thellenberg-Karlsson C, Adami HO, Grönberg H.

Prostate. 2006 Oct 1;66(14):1512-20.

PMID:
16921512
14.

Dietary phytoestrogen, serum enterolactone and risk of prostate cancer: the cancer prostate Sweden study (Sweden).

Hedelin M, Klint A, Chang ET, Bellocco R, Johansson JE, Andersson SO, Heinonen SM, Adlercreutz H, Adami HO, Grönberg H, Bälter KA.

Cancer Causes Control. 2006 Mar;17(2):169-80.

PMID:
16425095
15.

Interleukin-1 receptor antagonist haplotype associated with prostate cancer risk.

Lindmark F, Zheng SL, Wiklund F, Bälter KA, Sun J, Chang B, Hedelin M, Clark J, Johansson JE, Meyers DA, Adami HO, Isaacs W, Grönberg H, Xu J.

Br J Cancer. 2005 Aug 22;93(4):493-7.

16.

Alcohol drinking and risk of localized versus advanced and sporadic versus familial prostate cancer in Sweden.

Chang ET, Hedelin M, Adami HO, Grönberg H, Bälter KA.

Cancer Causes Control. 2005 Apr;16(3):275-84.

PMID:
15947879
17.

Interleukin-6 sequence variants are not associated with prostate cancer risk.

Sun J, Hedelin M, Zheng SL, Adami HO, Bensen J, Augustsson-Bälter K, Chang B, Adolfsson J, Adams T, Turner A, Meyers DA, Isaacs WB, Xu J, Grönberg H.

Cancer Epidemiol Biomarkers Prev. 2004 Oct;13(10):1677-9. No abstract available.

18.

H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer.

Lindmark F, Zheng SL, Wiklund F, Bensen J, Bälter KA, Chang B, Hedelin M, Clark J, Stattin P, Meyers DA, Adami HO, Isaacs W, Grönberg H, Xu J.

J Natl Cancer Inst. 2004 Aug 18;96(16):1248-54.

PMID:
15316060
19.

Re: Zinc supplement use and risk of prostate cancer.

Chang ET, Hedelin M, Adami HO, Grönberg H, Bälter KA.

J Natl Cancer Inst. 2004 Jul 21;96(14):1108; author reply 1108-9. No abstract available.

PMID:
15265974
20.

Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the CAncer Prostate in Sweden Study.

Zheng SL, Augustsson-Bälter K, Chang B, Hedelin M, Li L, Adami HO, Bensen J, Li G, Johnasson JE, Turner AR, Adams TS, Meyers DA, Isaacs WB, Xu J, Grönberg H.

Cancer Res. 2004 Apr 15;64(8):2918-22.

Supplemental Content

Loading ...
Support Center